Abstract:BackgroundOur nephrology fellowship requires specific training in recognition and referral of end-stage renal disease patients likely to benefit from palliative and hospice care.MethodsTo identify end-of-life (EOL) referral barriers that require greater training emphasis, we performed a cross-sectional, 17-item anonymous online survey (August–October 2015) of 93 nephrologists associated with the program since 1987.ResultsThere was a 61% response rate (57/93 surveys). Ninety-five percent practiced clinical neph… Show more
“…Among patients who died in inpatient facilities in the Veteran Affairs health care system, only half of patients on ESKD received palliative care services compared with almost three quarters of patients with cancer (5). This underutilization may be because of the uncertainty of disease trajectory for patients with ESKD (37,38) and inadequate training in endof-life care in nephrologists (39,40). In addition, the requirement of foregoing dialysis to qualify for the hospice Medicare benefit, unless the patient has a second terminal diagnosis unrelated to kidney failure, may contribute to the low rate of hospice enrollment (or utilization) for patients with ESKD (38).…”
Section: Discussionmentioning
confidence: 99%
“…This underutilization may be because of the uncertainty of disease trajectory for patients with ESKD (37,38) and inadequate training in endof-life care in nephrologists (39,40). In addition, the requirement of foregoing dialysis to qualify for the hospice Medicare benefit, unless the patient has a second terminal diagnosis unrelated to kidney failure, may contribute to the low rate of hospice enrollment (or utilization) for patients with ESKD (38). Moreover, although our institution benefits from an outpatient palliative care clinic offering services to patients on HD, studies suggest that fewer than 20% of institutions have outpatient palliative care services available (41), making inpatient palliative care consultation the only option for the majority of patients.…”
In this single-center study, the rate of hemodialysis withdrawals were twice the frequency previously described. Acute medical complications and frailty appeared to be driving factors. However, palliative care services were used in only a minority of patients.
“…Among patients who died in inpatient facilities in the Veteran Affairs health care system, only half of patients on ESKD received palliative care services compared with almost three quarters of patients with cancer (5). This underutilization may be because of the uncertainty of disease trajectory for patients with ESKD (37,38) and inadequate training in endof-life care in nephrologists (39,40). In addition, the requirement of foregoing dialysis to qualify for the hospice Medicare benefit, unless the patient has a second terminal diagnosis unrelated to kidney failure, may contribute to the low rate of hospice enrollment (or utilization) for patients with ESKD (38).…”
Section: Discussionmentioning
confidence: 99%
“…This underutilization may be because of the uncertainty of disease trajectory for patients with ESKD (37,38) and inadequate training in endof-life care in nephrologists (39,40). In addition, the requirement of foregoing dialysis to qualify for the hospice Medicare benefit, unless the patient has a second terminal diagnosis unrelated to kidney failure, may contribute to the low rate of hospice enrollment (or utilization) for patients with ESKD (38). Moreover, although our institution benefits from an outpatient palliative care clinic offering services to patients on HD, studies suggest that fewer than 20% of institutions have outpatient palliative care services available (41), making inpatient palliative care consultation the only option for the majority of patients.…”
In this single-center study, the rate of hemodialysis withdrawals were twice the frequency previously described. Acute medical complications and frailty appeared to be driving factors. However, palliative care services were used in only a minority of patients.
“…Six percent cited a lack of available hospice resources in their region; 27% said referral and end-of-life (EOL) discussions were too time consuming; and 69% felt patients had misconceptions about end-of-life (EOL) care. Encouragingly, 92% of these nephrologists felt comfortable having EOL care discussions with their patients (Ceckowski, Little, Merighi, Browne, & Yuan, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Table 1. Nephrology Survey 2015: Barriers to EOL Discussions in ESRD Patients (Ceckowski, Little, Merighi, Browne, & Yuan, 2017) Predominant Barriers § Time-consuming nature of discussions (27%) § Difficulty in determining prognosis for < 6-month survival (35%) § Patient (63%) and family (71%) unwillingness § Patient (69%) and family (73%) misconceptions § Lack of palliative care (12%) and hospice (6%) resources…”
This article identifies how clinical social workers in medical-surgical, mental health, and nephrology settings at Walter Reed National Military Medical Center (WRNMMC) and the End-Stage Renal Disease (ESRD) Network 5 Mid-Atlantic Renal Coalition assist nephrologists and other physicians in overcoming barriers to end-of-life (EOL) care planning, particularly in patients with end-stage renal disease (ESRD) or acute kidney injury (AKI). To assess differences in practice patterns, an anonymous survey was administered to determine whether social workers were comfortable having EOL care discussions with their patients, and to also assess if these social workers were able to assist the physicians with EOL care planning. Findings showed that social workers identified multiple barriers to discussing EOL care planning. Participants also identified the most important conversations to have when discussing EOL care planning with their patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.